Artelo Biosciences, Inc.

NasdaqCM:ARTL Stock Report

Market Cap: US$4.2m

Artelo Biosciences Balance Sheet Health

Financial Health criteria checks 4/6

Artelo Biosciences has a total shareholder equity of $9.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $10.4M and $817.0K respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$7.61m
EquityUS$9.54m
Total liabilitiesUS$817.00k
Total assetsUS$10.35m

Recent financial health updates

Recent updates

Artelo jumps 21% as publication highlights pre-clinical data on drug platform

Aug 16

Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans

Mar 28
Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans

Artelo Biosciences Rounding A Corner With Cannabinoid-Based Therapy

Mar 09

Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?

Nov 02
Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?

Relief For Cancer Patients In Artelo Bioscience Pipeline

Jul 12

Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans

May 20
Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans

Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?

Feb 04
Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?

INO, VXRT, BTU and TTM among premarket gainers

Feb 02

Artelo Biosciences EPS misses by $0.04

Jan 14

Artelo Biosciences on go with cancer appetite recovery study

Nov 16

Financial Position Analysis

Short Term Liabilities: ARTL's short term assets ($8.2M) exceed its short term liabilities ($721.0K).

Long Term Liabilities: ARTL's short term assets ($8.2M) exceed its long term liabilities ($96.0K).


Debt to Equity History and Analysis

Debt Level: ARTL is debt free.

Reducing Debt: ARTL had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ARTL has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ARTL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 22.8% each year


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.